Sachs Associates would like to say we enjoyed hosting you at our 9th Annual Neuroscience Innovation Forum (#Sachs_NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually. A special thank you goes to the excellent lineup of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible.
Once again, the forum demonstrated its strong value to the neuroscience community, with over 440 participants from 22 countries registered and a record number of in-person attendees.
We look forward to welcoming you again to our future events!
SILVER SPONSOR:
Presenting Companies Included:
Confirmed Keynote Speakers Included:
Andres Acosta
Director of Nutrition Obesity Program & Associate Professor of Medicine, Mayo Clinic
David Risinger
Senior Managing Director, Diversified Biopharmaceuticals Research, Leerink Partners LLC
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Kenneth Custer
EVP & President, Lilly Cardiometabolic Health, Eli Lilly and Company
Matthew Maryniak
President, Fenix Group International, LLC
Ting (Tim) Xiao
CFO, Eccogene Inc.
Speakers and Chairs Included:
Andres Acosta
Director of Nutrition Obesity Program & Associate Professor of Medicine, Mayo Clinic
Christopher Stern
Managing Director, L.E.K. Consulting
David Risinger
Senior Managing Director, Diversified Biopharmaceuticals Research, Leerink Partners LLC
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
John Westwood
Senior Vice President, Strategy Consulting, Lumanity
Michael Rice
Expert Advisor, SVP, Cell & Gene Therapy, Lumanity
Steve Dickman
CEO, CBT Advisors
Yury Kukushkin
Investment Partner, Hevolution
Anna Jen Beuchat
Director Business Development, F. Hoffmann-La Roche AG
Bei Zhang
Global Scientific Advisor, R&D External Innovation, Novo Nordisk A/S
Benjamin Yaden
Vice President - External Innovation-Cardiometabolic Health, Women's Health & Healthy Aging , Eli Lilly and Company
Blythe Sather
SVP Head of Research, Tune Therapeutics
Brady Miller
Director & Head of Syndicated Services, Fenix Group International, LLC
Brian Bloomquist
Chief Business & Strategy Officer, Alveus Therapeutics, Inc.
David Risinger
Senior Managing Director, Diversified Biopharmaceuticals Research, Leerink Partners LLC
David Kendall
Chief Medical Officer, Zealand Pharma A/S
Erik Ingelsson
Chief Scientific Officer, Wave Life Sciences
Frederick Beddingfield
CEO & Director, Rubedo Life Sciences
Harry Robb
Principal, Lifespan Vision Ventures LLC
Jamie Coleman
Chief Commercial Officer, Kailera Therapeutics
Jon Rees
CEO, MitoRx Therapeutics
Jyothis George
Chief Medical Officer, NodThera, Inc.
Kevin Slawin
Founder & CEO, Eos SENOLYTIX, Inc.
Laurent Audoly
Founder & CEO, PriveBio, Inc.
Lloyd Diamond
CEO, Nitinotes Ltd.
Mads Tang-Christensen
Chief Scientific Officer, Antag Therapeutics
Marija Mavar
President, Pharma Solutions, Perspectum Ltd.
Melissa Jones
Director, Metabolic Disorders, Foundation for the National Institutes of Health (FNIH)
Olivier Soula
Co-Founder & CEO, ADOCIA
Paul Rubin
Chief Medical Officer, BioAge Labs, Inc.
Robert Augustin
Director Strategic Partnering Cardiorenalmetabolism, Global BD&L, Boehringer Ingelheim International GmbH